Simplex Trading, LLC I Bio, Inc. Transaction History

Simplex Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$0.23 - $0.46 $3,119 - $6,239	13,564 Added 13564.0%	13,664 $3,000
Q1 2022 May 02, 2022	SELL	$0.3 - $0.61 $1,984 - $4,035	-6,615 Reduced 98.51%	100 $0
Q4 2021 Feb 23, 2022	BUY	$0.55 - $1.04 $3,472 - $6,565	6,313 Added 1570.4%	6,715 $3,000
Q3 2021 Oct 28, 2021	SELL	$1.06 - $1.52 $1,166 - $1,672	-1,100 Reduced 73.24%	402 $0
Q2 2021 Aug 12, 2021	SELL	$1.22 - $1.65 $55,954 - $75,675	-45,864 Reduced 96.83%	1,502 $2,000
Q1 2021 Apr 26, 2021	SELL	$1.18 - $2.62 $2,469 - $5,483	-2,093 Reduced 4.23%	47,366 $72,000
Q4 2020 Feb 02, 2021	BUY	$1.05 - $2.24 $51,144 - $109,108	48,709 Added 6494.53%	49,459 $51,000
Q3 2020 Oct 14, 2020	BUY	$1.7 - $6.41 $1,275 - $4,807	750 New	750 $1,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.